{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:06:56Z","timestamp":1791234416178,"version":"4.1.0"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-019-0086-z","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:02:52Z","timestamp":1558591372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Barrett oesophagus"],"prefix":"10.1038","volume":"5","author":[{"given":"Yonne","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al-Kaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Chak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda F.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad G.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"86_CR1","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"SJ Spechler","year":"2011","unstructured":"Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M. & Shaheen, N. J. American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus. Gastroenterology 140, 1084\u20131091 (2011).","journal-title":"Gastroenterology"},{"key":"86_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ajg.2015.322","volume":"111","author":"NJ Shaheen","year":"2016","unstructured":"Shaheen, N. J., Falk, G. W., Iyer, P. G. & Gerson, L. B. ACG clinical guideline: diagnosis and management of Barrett\u2019s esophagus. Am. J. Gastroenterol. 111, 30\u201350 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald, R. C. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut 63, 7\u201342 (2014).","journal-title":"Gut"},{"key":"86_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.gie.2012.08.004","volume":"76","author":"JA Evans","year":"2012","unstructured":"Evans, J. A. et al. The role of endoscopy in Barrett\u2019s esophagus and other premalignant conditions of the\u00a0esophagus. Gastrointest. Endosc. 76, 1087\u20131094 (2012).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen, J. et al. Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825\u20131831 (2005).","journal-title":"Gastroenterology"},{"key":"86_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","volume":"125","author":"DK Rex","year":"2003","unstructured":"Rex, D. K. et al. Screening for Barrett\u2019s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125, 1670\u20131677 (2003).","journal-title":"Gastroenterology"},{"key":"86_CR7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1053\/j.gastro.2018.08.036","volume":"155","author":"T Sawas","year":"2018","unstructured":"Sawas, T. et al. Identification of prognostic phenotypes of esophageal adenocarcinoma in two independent cohorts. Gastroenterology 155, 1720\u20131728 (2018).","journal-title":"Gastroenterology"},{"key":"86_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001780","volume":"12","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes, C. S. et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case-control study. PLOS Med. 12, e1001780 (2015).","journal-title":"PLOS Med."},{"key":"86_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrgastro.2015.24","volume":"12","author":"TL Vaughan","year":"2015","unstructured":"Vaughan, T. L. & Fitzgerald, R. C. Precision prevention of oesophageal adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 12, 243\u2013248 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold, M., Laversanne, M., Brown, L. M., Devesa, S. S. & Bray, F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am. J. Gastroenterol. 112, 1247\u20131255 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/ajg.2011.130","volume":"106","author":"KW Jung","year":"2011","unstructured":"Jung, K. W. et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett\u2019s esophagus: a population-based study. Am. J. Gastroenterol. 106, 1447\u20131455 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1442-2050.2008.00908.x","volume":"22","author":"J Alcedo","year":"2009","unstructured":"Alcedo, J. et al. Trends in Barrett\u2019s esophagus diagnosis in Southern Europe: implications for surveillance. Dis. Esophagus 22, 239\u2013248 (2009).","journal-title":"Dis. Esophagus"},{"key":"86_CR13","doi-asserted-by":"publisher","first-page":"c4372","DOI":"10.1136\/bmj.c4372","volume":"341","author":"SR Kadri","year":"2010","unstructured":"Kadri, S. R. et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett\u2019s oesophagus in primary care: cohort study. BMJ 341, c4372 (2010). This prospective study screens individuals with long-term PPI use for BE using the minimally invasive Cytosponge.","journal-title":"BMJ"},{"key":"86_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825\u2013831 (1999).","journal-title":"N. Engl. J. Med."},{"key":"86_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cgh.2018.08.066","volume":"17","author":"EC Lin","year":"2018","unstructured":"Lin, E. C., Holub, J., Lieberman, D. & Hur, C. Low prevalence of suspected Barrett\u2019s esophagus in patients with gastroesophageal reflux disease without alarm symptoms. Clin. Gastroenterol. Hepatol. 17, 857\u2013863 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/gast.2000.9302","volume":"119","author":"NJ Shaheen","year":"2000","unstructured":"Shaheen, N. J., Crosby, M. A., Bozymski, E. M. & Sandler, R. S. Is there publication bias in the reporting of cancer risk in Barrett\u2019s esophagus? Gastroenterology 119, 333\u2013338 (2000).","journal-title":"Gastroenterology"},{"key":"86_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sorensen, H. T. & Funch-Jensen, P. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N. Engl. J. Med. 365, 1375\u20131383 (2011).","journal-title":"N. Engl. J. Med."},{"key":"86_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cgh.2018.08.033","volume":"17","author":"Y Peters","year":"2018","unstructured":"Peters, Y. et al. Incidence of progression of persistent non-dysplastic Barrett\u2019s esophagus to malignancy. Clin. Gastroenterol. Hepatol. 17, 869\u2013877 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/aje\/kwr117","volume":"174","author":"CM Olsen","year":"2011","unstructured":"Olsen, C. M. et al. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am. J. Epidemiol. 174, 582\u2013590 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"86_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cgh.2007.10.006","volume":"6","author":"JA Abrams","year":"2008","unstructured":"Abrams, J. A., Fields, S., Lightdale, C. J. & Neugut, A. I. Racial and ethnic disparities in the prevalence of Barrett\u2019s esophagus among patients who undergo upper endoscopy. Clin. Gastroenterol. Hepatol. 6, 30\u201334 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s10620-009-0742-3","volume":"54","author":"A Wang","year":"2009","unstructured":"Wang, A., Mattek, N. C., Holub, J. L., Lieberman, D. A. & Eisen, G. M. Prevalence of complicated gastroesophageal reflux disease and Barrett\u2019s esophagus among racial groups in a multi-center consortium. Dig. Dis. Sci. 54, 964\u2013971 (2009).","journal-title":"Dig. Dis. Sci."},{"key":"86_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1442-2050.2011.01316.x","volume":"26","author":"K Keyashian","year":"2013","unstructured":"Keyashian, K. et al. Barrett\u2019s esophagus in Latinos undergoing endoscopy for gastroesophageal reflux disease symptoms. Dis. Esophagus 26, 44\u201349 (2013).","journal-title":"Dis. Esophagus"},{"key":"86_CR23","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.cgh.2015.07.050","volume":"13","author":"S Shiota","year":"2015","unstructured":"Shiota, S., Singh, S., Anshasi, A. & El-Serag, H. B. Prevalence of Barrett\u2019s esophagus in Asian countries: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 13, 1907\u20131918 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/aje\/kwi325","volume":"162","author":"MB Cook","year":"2005","unstructured":"Cook, M. B., Wild, C. P. & Forman, D. A systematic review and meta-analysis of the sex ratio for Barrett\u2019s esophagus, erosive reflux disease, and nonerosive reflux disease. Am. J. Epidemiol. 162, 1050\u20131061 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"86_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ajg.2009.137","volume":"104","author":"ZR Edelstein","year":"2009","unstructured":"Edelstein, Z. R., Bronner, M. P., Rosen, S. N. & Vaughan, T. L. Risk factors for Barrett\u2019s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am. J. Gastroenterol. 104, 834\u2013842 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.mayocp.2018.04.022","volume":"93","author":"WM Westra","year":"2018","unstructured":"Westra, W. M. et al. Smokeless tobacco and cigar and\/or pipe are risk factors for Barrett esophagus in male patients with gastroesophageal reflux disease. Mayo Clin. Proc. 93, 1282\u20131289 (2018).","journal-title":"Mayo Clin. Proc."},{"key":"86_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2011.12.049","volume":"142","author":"MB Cook","year":"2012","unstructured":"Cook, M. B. et al. Cigarette smoking increases risk of Barrett\u2019s esophagus: an analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Gastroenterology 142, 744\u2013753 (2012).","journal-title":"Gastroenterology"},{"key":"86_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep27334","volume":"6","author":"Z Zhao","year":"2016","unstructured":"Zhao, Z. et al. Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett\u2019s esophagus risk: a systematic review and meta-analysis. Sci. Rep. 6, 27334 (2016).","journal-title":"Sci. Rep."},{"key":"86_CR29","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1055-9965.EPI-13-0032","volume":"22","author":"AP Keszei","year":"2013","unstructured":"Keszei, A. P. et al. Meat consumption and the risk of Barrett\u2019s esophagus in a large Dutch cohort. Cancer Epidemiol. Biomarkers Prev. 22, 1162\u20131166 (2013).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"86_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1053\/gast.2002.32963","volume":"122","author":"K Iijima","year":"2002","unstructured":"Iijima, K. et al. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 122, 1248\u20131257 (2002).","journal-title":"Gastroenterology"},{"key":"86_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/003655202317284147","volume":"37","author":"A Moriya","year":"2002","unstructured":"Moriya, A. et al. In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand. J. Gastroenterol. 37, 253\u2013261 (2002).","journal-title":"Scand. J. Gastroenterol."},{"key":"86_CR32","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/ajg.2011.89","volume":"106","author":"AP Thrift","year":"2011","unstructured":"Thrift, A. P. et al. Lifetime alcohol consumption and risk of Barrett\u2019s esophagus. Am. J. Gastroenterol. 106, 1220\u20131230 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR33","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/j.gastro.2008.11.042","volume":"136","author":"A Kubo","year":"2009","unstructured":"Kubo, A. et al. Alcohol types and sociodemographic characteristics as risk factors for Barrett\u2019s esophagus. Gastroenterology 136, 806\u2013815 (2009).","journal-title":"Gastroenterology"},{"key":"86_CR34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh, S. et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1399\u20131412 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR35","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1136\/gutjnl-2012-303753","volume":"62","author":"A Kubo","year":"2013","unstructured":"Kubo, A. et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett\u2019s oesophagus: a pooled analysis from the International BEACON Consortium. Gut 62, 1684\u20131691 (2013).","journal-title":"Gut"},{"key":"86_CR36","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.cgh.2015.06.041","volume":"13","author":"AK Chandar","year":"2015","unstructured":"Chandar, A. K. et al. Association of serum levels of adipokines and insulin with risk of Barrett\u2019s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 13, 2241\u20132255 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR37","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s11605-009-0930-7","volume":"13","author":"S Ayazi","year":"2009","unstructured":"Ayazi, S. et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J. Gastrointest. Surg. 13, 1440\u20131447 (2009).","journal-title":"J. Gastrointest. Surg."},{"key":"86_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2006.12.032","volume":"132","author":"JC Wu","year":"2007","unstructured":"Wu, J. C., Mui, L. M., Cheung, C. M., Chan, Y. & Sung, J. J. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 132, 883\u2013889 (2007).","journal-title":"Gastroenterology"},{"key":"86_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3109\/00365521.2012.733952","volume":"47","author":"A Leodolter","year":"2012","unstructured":"Leodolter, A. et al. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett\u2019s esophagus: an entity of concern in the ProGERD study. Scand. J. Gastroenterol. 47, 1429\u20131435 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"86_CR40","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.5657","volume":"315","author":"KB Dunbar","year":"2016","unstructured":"Dunbar, K. B. et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA 315, 2104\u20132112 (2016).","journal-title":"JAMA"},{"key":"86_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archsurg.1983.01390050027005","volume":"118","author":"C Iascone","year":"1983","unstructured":"Iascone, C., DeMeester, T. R., Little, A. G. & Skinner, D. B. Barrett\u2019s esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch. Surg. 118, 543\u2013549 (1983).","journal-title":"Arch. Surg."},{"key":"86_CR42","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/0016-5085(90)90285-9","volume":"98","author":"MJ Collen","year":"1990","unstructured":"Collen, M. J., Lewis, J. H. & Benjamin, S. B. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 98, 654\u2013661 (1990).","journal-title":"Gastroenterology"},{"key":"86_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/BF01538064","volume":"34","author":"MW Mulholland","year":"1989","unstructured":"Mulholland, M. W., Reid, B. J., Levine, D. S. & Rubin, C. E. Elevated gastric acid secretion in patients with Barrett\u2019s metaplastic epithelium. Dig. Dis. Sci. 34, 1329\u20131334 (1989).","journal-title":"Dig. Dis. Sci."},{"key":"86_CR44","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/ajg.2010.194","volume":"105","author":"JB Taylor","year":"2010","unstructured":"Taylor, J. B. & Rubenstein, J. H. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett\u2019s esophagus. Am. J. Gastroenterol. 105, 1730\u20131737 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1572-0241.2006.00379.x","volume":"101","author":"EM Ward","year":"2006","unstructured":"Ward, E. M. et al. Barrett\u2019s esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am. J. Gastroenterol. 101, 12\u201317 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1440-1746.2012.07199.x","volume":"28","author":"J Andrici","year":"2013","unstructured":"Andrici, J., Tio, M., Cox, M. R. & Eslick, G. D. Hiatal hernia and the risk of Barrett\u2019s esophagus. J.\u00a0Gastroenterol. Hepatol. 28, 415\u2013431 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"86_CR47","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41395-018-0070-3","volume":"113","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Helicobacter pylori infection is associated with reduced risk of Barrett\u2019s esophagus: an analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Am. J. Gastroenterol. 113, 1148\u20131155 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12504","volume":"23","author":"B Eross","year":"2018","unstructured":"Eross, B. et al. Helicobacter pylori infection reduces the risk of Barrett\u2019s esophagus: a meta-analysis and systematic review. Helicobacter 23, e12504 (2018).","journal-title":"Helicobacter"},{"key":"86_CR49","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1158\/1055-9965.EPI-06-0293","volume":"15","author":"A Chak","year":"2006","unstructured":"Chak, A. et al. Familiality in Barrett\u2019s esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol. Biomarkers Prev. 15, 1668\u20131673 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"86_CR50","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.cgh.2014.01.028","volume":"12","author":"RE Verbeek","year":"2014","unstructured":"Verbeek, R. E. et al. Familial clustering of Barrett\u2019s esophagus and esophageal adenocarcinoma in a European cohort. Clin. Gastroenterol. Hepatol. 12, 1656\u20131663 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR51","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-2036.2011.04855.x","volume":"34","author":"AP Thrift","year":"2011","unstructured":"Thrift, A. P. et al. The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett\u2019s oesophagus. Aliment. Pharmacol. Ther. 34, 1235\u20131244 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s10620-015-3869-4","volume":"61","author":"IL Beales","year":"2016","unstructured":"Beales, I. L., Dearman, L., Vardi, I. & Loke, Y. Reduced risk of Barrett\u2019s esophagus in statin users: case-control study and meta-analysis. Dig. Dis. Sci. 61, 238\u2013246 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"86_CR53","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/SLA.0000000000002179","volume":"267","author":"CS Brown","year":"2018","unstructured":"Brown, C. S. et al. Predicting progression in Barrett\u2019s esophagus: development and validation of the Barrett\u2019s Esophagus Assessment of Risk Score (BEAR Score). Ann. Surg. 267, 716\u2013720 (2018).","journal-title":"Ann. Surg."},{"key":"86_CR54","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.3748\/wjg.v22.i48.10592","volume":"22","author":"P Gatenby","year":"2016","unstructured":"Gatenby, P., Bhattacharjee, S., Wall, C., Caygill, C. & Watson, A. Risk stratification for malignant progression in Barrett\u2019s esophagus: gender, age, duration and year of surveillance. World J. Gastroenterol. 22, 10592\u201310600 (2016).","journal-title":"World J. Gastroenterol."},{"key":"86_CR55","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cgh.2017.11.044","volume":"16","author":"R Krishnamoorthi","year":"2018","unstructured":"Krishnamoorthi, R. et al. Factors associated with progression of Barrett\u2019s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 16, 1046\u20131055 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR56","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2017.12.009","volume":"154","author":"S Parasa","year":"2018","unstructured":"Parasa, S. et al. Development and validation of a model to determine risk of progression of Barrett\u2019s esophagus to neoplasia. Gastroenterology 154, 1282\u20131289 (2018). This study of 2,697 patients with BE develops a scoring system based on male sex, smoking, length of BE and baseline LGD and identifies patients with BE at low risk, intermediate risk and high risk of EAC.","journal-title":"Gastroenterology"},{"key":"86_CR57","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat, S. et al. Risk of malignant progression in Barrett\u2019s esophagus patients: results from a large population-based study. J. Natl Cancer Inst. 103, 1049\u20131057 (2011).","journal-title":"J. Natl Cancer Inst."},{"key":"86_CR58","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/00365520701420735","volume":"42","author":"CJ Kelty","year":"2007","unstructured":"Kelty, C. J., Gough, M. D., Van Wyk, Q., Stephenson, T. J. & Ackroyd, R. Barrett\u2019s oesophagus: intestinal metaplasia is not essential for cancer risk. Scand. J.\u00a0Gastroenterol. 42, 1271\u20131274 (2007).","journal-title":"Scand. J. Gastroenterol."},{"key":"86_CR59","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1053\/j.gastro.2018.02.022","volume":"154","author":"DC Codipilly","year":"2018","unstructured":"Codipilly, D. C. et al. The effect of endoscopic surveillance in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis. Gastroenterology 154, 2068\u20132086 (2018). This systematic review and meta-analysis shows that surveillance of patients with BE is associated with detection of earlier-stage EAC and a small survival benefit.","journal-title":"Gastroenterology"},{"key":"86_CR60","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/j.gastro.2016.12.008","volume":"152","author":"LC Duits","year":"2017","unstructured":"Duits, L. C. et al. Patients with Barrett\u2019s esophagus and confirmed persistent low-grade dysplasia are at increased risk for progression to neoplasia. Gastroenterology 152, 993\u20131001 (2017).","journal-title":"Gastroenterology"},{"key":"86_CR61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cgh.2015.12.027","volume":"14","author":"C Kestens","year":"2016","unstructured":"Kestens, C., Offerhaus, G. J., van Baal, J. W. & Siersema, P. D. Patients with Barrett\u2019s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin. Gastroenterol. Hepatol. 14, 956\u2013962 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.gie.2007.07.019","volume":"67","author":"A Rastogi","year":"2008","unstructured":"Rastogi, A. et al. Incidence of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc. 67, 394\u2013398 (2008).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR63","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","volume":"360","author":"NJ Shaheen","year":"2009","unstructured":"Shaheen, N. J. et al. Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. N. Engl. J. Med. 360, 2277\u20132288 (2009). This sham-controlled randomized trial analyses whether endoscopic RFA could eradicate dysplastic BE and decrease the rate of malignant progression.","journal-title":"N. Engl. J. Med."},{"key":"86_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.gie.2005.06.047","volume":"62","author":"BF Overholt","year":"2005","unstructured":"Overholt, B. F. et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett\u2019s esophagus: international, partially blinded, randomized phase III trial. Gastrointest. Endosc. 62, 488\u2013498 (2005).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR65","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00535-017-1342-1","volume":"52","author":"RF Souza","year":"2017","unstructured":"Souza, R. F. Reflux esophagitis and its role in the pathogenesis of Barrett\u2019s metaplasia. J. Gastroenterol. 52, 767\u2013776 (2017).","journal-title":"J. Gastroenterol."},{"key":"86_CR66","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.humpath.2006.03.023","volume":"37","author":"JN Glickman","year":"2006","unstructured":"Glickman, J. N. et al. Mucin core polypeptide expression in the progression of neoplasia in Barrett\u2019s esophagus. Hum. Pathol. 37, 1304\u20131315 (2006).","journal-title":"Hum. Pathol."},{"key":"86_CR67","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/gutjnl-2013-306508","volume":"63","author":"DL Lavery","year":"2014","unstructured":"Lavery, D. L. et al. The stem cell organisation, and the proliferative and gene expression profile of Barrett\u2019s epithelium, replicates pyloric-type gastric glands. Gut 63, 1854\u20131863 (2014).","journal-title":"Gut"},{"key":"86_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2036.2011.04709.x","volume":"34","author":"KR McQuaid","year":"2011","unstructured":"McQuaid, K. R., Laine, L., Fennerty, M. B., Souza, R. & Spechler, S. J. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment. Pharmacol. Ther. 34, 146\u2013165 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR69","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.celrep.2014.03.074","volume":"7","author":"L Mari","year":"2014","unstructured":"Mari, L. et al. A pSMAD\/CDX2 complex is essential for the intestinalization of epithelial metaplasia. Cell Rep. 7, 1197\u20131210 (2014).","journal-title":"Cell Rep."},{"key":"86_CR70","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1053\/j.gastro.2010.01.048","volume":"138","author":"DH Wang","year":"2010","unstructured":"Wang, D. H. et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett\u2019s metaplasia. Gastroenterology 138, 1810\u20131822 (2010).","journal-title":"Gastroenterology"},{"key":"86_CR71","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature24269","volume":"550","author":"M Jiang","year":"2017","unstructured":"Jiang, M. et al. Transitional basal cells at the squamous-columnar junction generate Barrett\u2019s oesophagus. Nature 550, 529\u2013533 (2017).","journal-title":"Nature"},{"key":"86_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018280","volume":"6","author":"J Kong","year":"2011","unstructured":"Kong, J., Crissey, M. A., Funakoshi, S., Kreindler, J. L. & Lynch, J. P. Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett\u2019s esophagus. PLOS ONE 6, e18280 (2011).","journal-title":"PLOS ONE"},{"key":"86_CR73","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.4161\/15384101.2014.972875","volume":"13","author":"ME Vega","year":"2014","unstructured":"Vega, M. E. et al. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett\u2019s-like metaplasia via KLF4. Cell Cycle 13, 3857\u20133866 (2014).","journal-title":"Cell Cycle"},{"key":"86_CR74","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrm2146","volume":"8","author":"JM Slack","year":"2007","unstructured":"Slack, J. M. Metaplasia and transdifferentiation: from pure biology to the clinic. Nature reviews. Mol. Cell Biol. 8, 369\u2013378 (2007).","journal-title":"Nature reviews. Mol. Cell Biol."},{"key":"86_CR75","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/modpathol.3800182","volume":"17","author":"GM Groisman","year":"2004","unstructured":"Groisman, G. M., Amar, M. & Meir, A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett\u2019s) metaplasia. Mod. Pathol. 17, 1282\u20131288 (2004).","journal-title":"Mod. Pathol."},{"key":"86_CR76","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1042\/BST0380370","volume":"38","author":"M Barbera","year":"2010","unstructured":"Barbera, M. & Fitzgerald, R. C. Cellular origin of Barrett\u2019s metaplasia and oesophageal stem cells. Biochem. Soc. Trans. 38, 370\u2013373 (2010).","journal-title":"Biochem. Soc. Trans."},{"key":"86_CR77","first-page":"176","volume":"115","author":"H Li","year":"1994","unstructured":"Li, H. et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett\u2019s esophagus. Surgery 115, 176\u2013181 (1994).","journal-title":"Surgery"},{"key":"86_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2011.12.004","volume":"21","author":"M Quante","year":"2012","unstructured":"Quante, M. et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21, 36\u201351 (2012).","journal-title":"Cancer Cell"},{"key":"86_CR79","doi-asserted-by":"publisher","DOI":"10.1101\/517565","author":"K K\u00fcbler","year":"2019","unstructured":"K\u00fcbler, K. et al. Tumor mutational landscape is a record of the pre-malignant state. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/517565 (2019).","journal-title":"bioRxiv"},{"key":"86_CR80","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"The Cancer Genome Atlas Research Network","year":"2017","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169\u2013175 (2017).","journal-title":"Nature"},{"key":"86_CR81","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.1804","volume":"206","author":"RA Coad","year":"2005","unstructured":"Coad, R. A. et al. On the histogenesis of Barrett\u2019s oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts. J.\u00a0Pathol. 206, 388\u2013394 (2005).","journal-title":"J. Pathol."},{"key":"86_CR82","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/gut.2007.143339","volume":"57","author":"SJ Leedham","year":"2008","unstructured":"Leedham, S. J. et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett\u2019s oesophagus. Gut 57, 1041\u20131048 (2008).","journal-title":"Gut"},{"key":"86_CR83","doi-asserted-by":"publisher","first-page":"G180","DOI":"10.1152\/ajpgi.00036.2017","volume":"313","author":"L Kruger","year":"2017","unstructured":"Kruger, L. et al. Ductular and proliferative response of esophageal submucosal glands in a porcine model of esophageal injury and repair. Am. J. Physiol. Gastrointest. Liver Physiol. 313, G180\u2013G191 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"86_CR84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jcmgh.2017.07.005","volume":"4","author":"RJ von Furstenberg","year":"2017","unstructured":"von Furstenberg, R. J. et al. Porcine esophageal submucosal gland culture model shows capacity for proliferation and differentiation. Cell. Mol. Gastroenterol. Hepatol. 4, 385\u2013404 (2017).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"86_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06796-9","volume":"9","author":"RP Owen","year":"2018","unstructured":"Owen, R. P. et al. Single cell RNA-seq reveals profound transcriptional similarity between Barrett\u2019s oesophagus and oesophageal submucosal glands. Nat. Commun. 9, 4261 (2018).","journal-title":"Nat. Commun."},{"key":"86_CR86","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cell.2011.05.026","volume":"145","author":"X Wang","year":"2011","unstructured":"Wang, X. et al. Residual embryonic cells as precursors of a Barrett\u2019s-like metaplasia. Cell 145, 1023\u20131035 (2011).","journal-title":"Cell"},{"key":"86_CR87","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1242\/jcs.115.9.1783","volume":"115","author":"JP Seery","year":"2002","unstructured":"Seery, J. P. Stem cells of the oesophageal epithelium. J. Cell Sci. 115, 1783\u20131789 (2002).","journal-title":"J. Cell Sci."},{"key":"86_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/scd.2010.0139","volume":"20","author":"L Hutchinson","year":"2011","unstructured":"Hutchinson, L. et al. Human Barrett\u2019s adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. Stem Cells Dev. 20, 11\u201317 (2011).","journal-title":"Stem Cells Dev."},{"key":"86_CR89","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/cts.12304","volume":"8","author":"H Kapoor","year":"2015","unstructured":"Kapoor, H., Lohani, K. R., Lee, T. H., Agrawal, D. K. & Mittal, S. K. Animal models of Barrett\u2019s esophagus and esophageal adenocarcinoma-past, present, and future. Clin. Transl Sci. 8, 841\u2013847 (2015).","journal-title":"Clin. Transl Sci."},{"key":"86_CR90","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cgh.2018.03.007","volume":"16","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. Interactions between genetic variants and environmental factors affect risk of esophageal adenocarcinoma and Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 16, 1598\u20131606 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR91","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.12.003","volume":"154","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. Determining risk of Barrett\u2019s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants. Gastroenterology 154, 1273\u20131281 (2018).","journal-title":"Gastroenterology"},{"key":"86_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184962","volume":"12","author":"X Sun","year":"2017","unstructured":"Sun, X. et al. Genomic regions associated with susceptibility to Barrett\u2019s esophagus and esophageal adenocarcinoma in African Americans: the cross BETRNet admixture study. PLOS ONE 12, e0184962 (2017).","journal-title":"PLOS ONE"},{"key":"86_CR93","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/jnci\/djt303","volume":"105","author":"WE Ek","year":"2013","unstructured":"Ek, W. E. et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett\u2019s esophagus, and gastroesophageal reflux. J. Natl Cancer Inst. 105, 1711\u20131718 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"86_CR94","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S1470-2045(16)30240-6","volume":"17","author":"P Gharahkhani","year":"2016","unstructured":"Gharahkhani, P. et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett\u2019s oesophagus: a large-scale meta-analysis. Lancet. Oncol. 17, 1363\u20131373 (2016). This meta-analysis of all GWASs of BE and EAC investigates novel genetic risk variants for BE development and malignant progression.","journal-title":"Lancet. Oncol."},{"key":"86_CR95","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/gutjnl-2016-311622","volume":"66","author":"MF Buas","year":"2017","unstructured":"Buas, M. F. et al. Germline variation in inflammation-related pathways and risk of Barrett\u2019s oesophagus and oesophageal adenocarcinoma. Gut 66, 1739\u20131747 (2017).","journal-title":"Gut"},{"key":"86_CR96","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1158\/1055-9965.EPI-15-0507","volume":"24","author":"JY Dai","year":"2015","unstructured":"Dai, J. Y. et al. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett\u2019s esophagus. Cancer Epidemiol. Biomarkers Prev. 24, 1739\u20131747 (2015).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"86_CR97","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"86_CR98","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/ajg.2009.437","volume":"104","author":"M Sikkema","year":"2009","unstructured":"Sikkema, M. et al. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett\u2019s esophagus: a case-control study. Am. J. Gastroenterol. 104, 2673\u20132680 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR99","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2036.2001.01046.x","volume":"15","author":"RF Souza","year":"2001","unstructured":"Souza, R. F., Morales, C. P. & Spechler, S. J. Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett\u2019s oesophagus. Aliment. Pharmacol. Ther. 15, 1087\u20131100 (2001).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR100","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ng.3343","volume":"47","author":"MD Stachler","year":"2015","unstructured":"Stachler, M. D. et al. Paired exome analysis of Barrett\u2019s esophagus and adenocarcinoma. Nat. Genet. 47, 1047\u20131055 (2015). This paper investigates the malignant progression of BE to EAC by whole-exome sequencing and shows that the emergence of EAC follows a more rapid pathway that involves genome duplication.","journal-title":"Nat. Genet."},{"key":"86_CR101","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng.3357","volume":"47","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes, C. S. et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett\u2019s esophagus and esophageal adenocarcinoma. Nat. Genet. 47, 1038\u20131046 (2015).","journal-title":"Nat. Genet."},{"key":"86_CR102","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ng.3013","volume":"46","author":"JMJ Weaver","year":"2014","unstructured":"Weaver, J. M. J. et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat. Genet. 46, 837\u2013843 (2014).","journal-title":"Nat. Genet."},{"key":"86_CR103","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41588-018-0331-5","volume":"51","author":"AM Frankell","year":"2019","unstructured":"Frankell, A. M. et al. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nat. Genet. 51, 506\u2013516 (2019).","journal-title":"Nat. Genet."},{"key":"86_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12158","volume":"7","author":"P Martinez","year":"2016","unstructured":"Martinez, P. et al. Dynamic clonal equilibrium and predetermined cancer risk in Barrett\u2019s oesophagus. Nat. Commun. 7, 12158 (2016).","journal-title":"Nat. Commun."},{"key":"86_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0476-9","volume":"12","author":"F Newell","year":"2019","unstructured":"Newell, F. et al. Complex structural rearrangements are present in high-grade dysplastic Barrett\u2019s oesophagus samples. BMC Med. Genomics 12, 31 (2019).","journal-title":"BMC Med. Genomics"},{"key":"86_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6224","volume":"5","author":"K Nones","year":"2014","unstructured":"Nones, K. et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat. Commun. 5, 5224 (2014).","journal-title":"Nat. Commun."},{"key":"86_CR107","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ajg.2017.154","volume":"112","author":"PM Moayyedi","year":"2017","unstructured":"Moayyedi, P. M. et al. ACG and CAG clinical guideline: management of dyspepsia. Am. J. Gastroenterol. 112, 988\u20131013 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR108","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.gie.2015.02.021","volume":"81","author":"VR Muthusamy","year":"2015","unstructured":"Muthusamy, V. R. et al. The role of endoscopy in the management of GERD. Gastrointest. Endosc. 81, 1305\u20131310 (2015).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR109","first-page":"191","volume":"49","author":"B Weusten","year":"2017","unstructured":"Weusten, B. et al. Endoscopic management of Barrett\u2019s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 49, 191\u2013198 (2017).","journal-title":"Endoscopy (ESGE) position statement. Endoscopy"},{"key":"86_CR110","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","volume":"51","author":"K Iwakiri","year":"2016","unstructured":"Iwakiri, K. et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J. Gastroenterol. 51, 751\u2013767 (2016).","journal-title":"J. Gastroenterol."},{"key":"86_CR111","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jgh.12913","volume":"30","author":"DC Whiteman","year":"2015","unstructured":"Whiteman, D. C. et al. Australian clinical practice guidelines for the diagnosis and management of Barrett\u2019s esophagus and early esophageal adenocarcinoma. J. Gastroenterol. Hepatol. 30, 804\u2013820 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"86_CR112","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gutjnl-2015-309220","volume":"65","author":"H Pohl","year":"2016","unstructured":"Pohl, H. et al. Length of Barrett\u2019s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut 65, 196\u2013201 (2016).","journal-title":"Gut"},{"key":"86_CR113","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2016.12.005","volume":"152","author":"PN Thota","year":"2017","unstructured":"Thota, P. N. et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett\u2019s esophagus less than 1cm (irregular Z line) within 5 years of index endoscopy. Gastroenterology 152, 987\u2013992 (2017).","journal-title":"Gastroenterology"},{"key":"86_CR114","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1053\/j.gastro.2015.08.007","volume":"149","author":"P Sharma","year":"2015","unstructured":"Sharma, P. et al. Quality indicators for the management of Barrett\u2019s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology 149, 1599\u20131606 (2015).","journal-title":"Gastroenterology"},{"key":"86_CR115","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2006.08.032","volume":"131","author":"P Sharma","year":"2006","unstructured":"Sharma, P. et al. The development and validation of an endoscopic grading system for Barrett\u2019s esophagus: the Prague C & M criteria. Gastroenterology 131, 1392\u20131399 (2006).","journal-title":"Gastroenterology"},{"key":"86_CR116","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.clinre.2018.06.004","volume":"42","author":"A Antony","year":"2018","unstructured":"Antony, A. et al. Adherence to quality indicators in endoscopic surveillance of Barrett\u2019s esophagus and correlation to dysplasia detection rates. Clin. Res. Hepatol. Gastroenterol. 42, 591\u2013596 (2018).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"86_CR117","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1055\/s-0043-109623","volume":"49","author":"J Ooi","year":"2017","unstructured":"Ooi, J. et al. Dedicated Barrett\u2019s surveillance sessions managed by trained endoscopists improve dysplasia detection rate. Endoscopy 49, C1 (2017).","journal-title":"Endoscopy"},{"key":"86_CR118","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1572-0241.2007.01230.x","volume":"102","author":"R Harrison","year":"2007","unstructured":"Harrison, R. et al. Detection of intestinal metaplasia in Barrett\u2019s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am. J. Gastroenterol. 102, 1154\u20131161 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR119","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0016-5085(99)70123-X","volume":"116","author":"WK Hirota","year":"1999","unstructured":"Hirota, W. K. et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116, 277\u2013285 (1999).","journal-title":"Gastroenterology"},{"key":"86_CR120","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper, R. J. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47, 251\u2013255 (2000).","journal-title":"Gut"},{"key":"86_CR121","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.gastro.2016.10.041","volume":"152","author":"P Vennalaganti","year":"2017","unstructured":"Vennalaganti, P. et al. Discordance among pathologists in the United States and Europe in diagnosis of low-grade dysplasia for patients with Barrett\u2019s esophagus. Gastroenterology 152, 564\u2013570 (2017).","journal-title":"Gastroenterology"},{"key":"86_CR122","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1572-0241.2007.01746.x","volume":"103","author":"JE Abela","year":"2008","unstructured":"Abela, J. E. et al. Systematic four-quadrant biopsy detects Barrett\u2019s dysplasia in more patients than nonsystematic biopsy. Am. J. Gastroenterol. 103, 850\u2013855 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR123","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.gie.2017.07.039","volume":"87","author":"PR Vennalaganti","year":"2018","unstructured":"Vennalaganti, P. R. et al. Increased detection of Barrett\u2019s esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointest. Endosc. 87, 348\u2013355 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/gutjnl-2011-300962","volume":"62","author":"P Sharma","year":"2013","unstructured":"Sharma, P. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett\u2019s oesophagus: a prospective, international, randomised controlled trial. Gut 62, 15\u201321 (2013).","journal-title":"Gut"},{"key":"86_CR125","first-page":"349","volume":"3","author":"DJ Waterhouse","year":"2018","unstructured":"Waterhouse, D. J., Fitzpatrick, C. R. M., di Pietro, M. & Bohndiek, S. E. Emerging optical methods for endoscopic surveillance of Barrett\u2019s oesophagus. Lancet Gastroenterol. Hepatol. 3, 349\u2013362 (2018).","journal-title":"Gastroenterol. Hepatol."},{"key":"86_CR126","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2015.11.040","volume":"150","author":"K Visrodia","year":"2016","unstructured":"Visrodia, K. et al. Magnitude of missed esophageal adenocarcinoma after Barrett\u2019s esophagus diagnosis: a systematic review and meta-analysis. Gastroenterology 150, 599\u2013607 (2016).","journal-title":"Gastroenterology"},{"key":"86_CR127","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective, Continuous Update Project Expert Report (World Cancer Research Fund International, 2018)."},{"key":"86_CR128","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MEG.0000000000000998","volume":"30","author":"S Lam","year":"2018","unstructured":"Lam, S., Alexandre, L., Luben, R. & Hart, A. R. The association between physical activity and the risk of symptomatic Barrett\u2019s oesophagus: a UK prospective cohort study. Eur. J. Gastroenterol. Hepatol. 30, 71\u201375 (2018).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"86_CR129","first-page":"1144","volume":"6","author":"AT Kunzmann","year":"2018","unstructured":"Kunzmann, A. T. et al. Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: a prospective cohort study within UK Biobank. United European Gastroenterol. J. 6, 1144\u20131154 (2018).","journal-title":"Gastroenterol. J."},{"key":"86_CR130","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00394-015-0975-1","volume":"55","author":"S Realdon","year":"2016","unstructured":"Realdon, S. et al. Adherence to WCRF\/AICR lifestyle recommendations for cancer prevention and the risk of Barrett\u2019s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population. Eur. J. Nutr. 55, 1563\u20131571 (2016).","journal-title":"Eur. J. Nutr."},{"key":"86_CR131","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1017\/S0007114511000742","volume":"106","author":"HG Mulholland","year":"2011","unstructured":"Mulholland, H. G., Murray, L. J., Anderson, L. A., Cantwell, M. M. & FINBAR study group. Vitamin\u00a0D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br. J. Nutr. 106, 732\u2013741 (2011).","journal-title":". Br. J. Nutr."},{"key":"86_CR132","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1017\/S0007114515004444","volume":"115","author":"Q Dai","year":"2016","unstructured":"Dai, Q. et al. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett\u2019s oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Br. J. Nutr. 115, 342\u2013350 (2016).","journal-title":"Br. J. Nutr."},{"key":"86_CR133","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2105\/AJPH.2004.045260","volume":"96","author":"CF Garland","year":"2006","unstructured":"Garland, C. F. et al. The role of vitamin\u00a0D in cancer prevention. Am. J. Public Health 96, 252\u2013261 (2006).","journal-title":"Am. J. Public Health"},{"key":"86_CR134","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejcn.2014.7","volume":"68","author":"DT Dibaba","year":"2014","unstructured":"Dibaba, D. T., Xun, P. & He, K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur. J. Clin. Nutr. 68, 510\u2013516 (2014).","journal-title":"Eur. J. Clin. Nutr."},{"key":"86_CR135","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","volume":"153","author":"MF Vaezi","year":"2017","unstructured":"Vaezi, M. F., Yang, Y. X. & Howden, C. W. Complications of proton pump inhibitor therapy. Gastroenterology 153, 35\u201348 (2017).","journal-title":"Gastroenterology"},{"key":"86_CR136","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/apt.13194","volume":"41","author":"SE Attwood","year":"2015","unstructured":"Attwood, S. E. et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment. Pharmacol. Ther. 41, 1162\u20131174 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR137","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1586\/17474124.2014.913478","volume":"8","author":"KE O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, K. E. et al. The role of inflammation in cancer of the esophagus. Expert Rev. Gastroenterol. Hepatol. 8, 749\u2013760 (2014).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"86_CR138","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","volume":"117","author":"R Ouatu-Lascar","year":"1999","unstructured":"Ouatu-Lascar, R., Fitzgerald, R. C. & Triadafilopoulos, G. Differentiation and proliferation in Barrett\u2019s esophagus and the effects of acid suppression. Gastroenterology 117, 327\u2013335 (1999).","journal-title":"Gastroenterology"},{"key":"86_CR139","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2036.2010.04428.x","volume":"32","author":"A Abu-Sneineh","year":"2010","unstructured":"Abu-Sneineh, A. et al. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett\u2019s oesophagus. Aliment. Pharmacol. Ther. 32, 1023\u20131030 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR140","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","volume":"63","author":"S Singh","year":"2014","unstructured":"Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G. & El-Serag, H. B. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis. Gut 63, 1229\u20131237 (2014).","journal-title":"Gut"},{"key":"86_CR141","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","volume":"392","author":"JAZ Jankowski","year":"2018","unstructured":"Jankowski, J. A. Z. et al. Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a randomised factorial trial. Lancet 392, 400\u2013408 (2018). This randomized trial of 2,557 patients with BE shows that the combination of high-dose PPI and aspirin is the best strategy to reduce the risk of EAC and HGD.","journal-title":"Lancet"},{"key":"86_CR142","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1053\/j.gastro.2011.11.019","volume":"142","author":"LM Liao","year":"2012","unstructured":"Liao, L. M. et al. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology 142, 442\u2013452 (2012).","journal-title":"Gastroenterology"},{"key":"86_CR143","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/bjc.2014.127","volume":"110","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus: a meta-analysis. Br. J. Cancer 110, 2378\u20132388 (2014).","journal-title":"Br. J. Cancer"},{"key":"86_CR144","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1572-0241.2007.01773.x","volume":"103","author":"OO Ogunwobi","year":"2008","unstructured":"Ogunwobi, O. O. & Beales, I. L. Statins inhibit proliferation and induce apoptosis in Barrett\u2019s esophageal adenocarcinoma cells. Am. J. Gastroenterol. 103, 825\u2013837 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR145","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/j.gastro.2014.04.040","volume":"147","author":"T Nguyen","year":"2014","unstructured":"Nguyen, T., Khalaf, N., Ramsey, D. & El-Serag, H. B. Statin use is associated with a decreased risk of Barrett\u2019s esophagus. Gastroenterology 147, 314\u2013323 (2014).","journal-title":"Gastroenterology"},{"key":"86_CR146","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2015.07.009","volume":"149","author":"T Nguyen","year":"2015","unstructured":"Nguyen, T., Duan, Z., Naik, A. D., Kramer, J. R. & El-Serag, H. B. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett\u2019s esophagus: a nested case-control study. Gastroenterology 149, 1392\u20131398 (2015).","journal-title":"Gastroenterology"},{"key":"86_CR147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11\u201330 (2013).","journal-title":"CA Cancer J. Clin."},{"key":"86_CR148","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ajg.2014.156","volume":"109","author":"RE Verbeek","year":"2014","unstructured":"Verbeek, R. E. et al. Surveillance of Barrett\u2019s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am. J. Gastroenterol. 109, 1215\u20131222 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR149","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","volume":"93","author":"RE Sampliner","year":"1998","unstructured":"Sampliner, R. E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 93, 1028\u20131032 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.2006.03138.x","volume":"25","author":"J Stoltey","year":"2007","unstructured":"Stoltey, J., Reeba, H., Ullah, N., Sabhaie, P. & Gerson, L. Does Barrett\u2019s oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease? Aliment. Pharmacol. Ther. 25, 83\u201391 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR151","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ajg.2012.446","volume":"108","author":"JH Rubenstein","year":"2013","unstructured":"Rubenstein, J. H. et al. Prediction of Barrett\u2019s esophagus among men. Am. J. Gastroenterol. 108, 353\u2013362 (2013). This article presents a study in which a prediction model for BE based on GERD, age, abdominal obesity and cigarette use with an AUC of 0.72 is developed in 822 male patients with colorectal cancer who are screened using upper endoscopy.","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR152","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cgh.2017.03.004","volume":"15","author":"AP Thrift","year":"2017","unstructured":"Thrift, A. P., Vaughan, T. L., Anderson, L. A., Whiteman, D. C. & El-Serag, H. B. External validation of the Michigan Barrett\u2019s esophagus prediction tool. Clin. Gastroenterol. Hepatol. 15, 1124\u20131126 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR153","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cgh.2013.12.014","volume":"12","author":"AP Thrift","year":"2014","unstructured":"Thrift, A. P., Garcia, J. M. & El-Serag, H. B. A multibiomarker risk score helps predict risk for Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 12, 1267\u20131271 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR154","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1053\/j.gastro.2018.03.031","volume":"154","author":"SJ Spechler","year":"2018","unstructured":"Spechler, S. J., Katzka, D. A. & Fitzgerald, R. C. New screening techniques in Barrett\u2019s esophagus: great ideas or great practice? Gastroenterology 154, 1594\u20131601 (2018).","journal-title":"Gastroenterology"},{"key":"86_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11938-018-0166-2","volume":"16","author":"SS Sami","year":"2018","unstructured":"Sami, S. S. & Iyer, P. G. Recent advances in screening for Barrett\u2019s esophagus. Curr. Treat. Options Gastroenterol. 16, 1\u201314 (2018).","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"86_CR156","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.gie.2015.07.016","volume":"82","author":"SS Sami","year":"2015","unstructured":"Sami, S. S. et al. Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI tract: systematic review and meta-analysis. Gastrointest. Endosc. 82, 782\u2013792 (2015).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR157","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ajg.2014.362","volume":"110","author":"SS Sami","year":"2015","unstructured":"Sami, S. S. et al. A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett\u2019s esophagus screening in the community. Am. J. Gastroenterol. 110, 148\u2013158 (2015). This randomized controlled trial shows that mobile and outpatient unsedated TNE may be an effective alternative to standard endoscopy to screen for BE.","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR158","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.gie.2017.04.019","volume":"87","author":"JP Moriarty","year":"2018","unstructured":"Moriarty, J. P. et al. Costs associated with Barrett\u2019s esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy. Gastrointest. Endosc. 87, 88\u201394 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR159","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.cgh.2018.07.019","volume":"17","author":"SS Sami","year":"2018","unstructured":"Sami, S. S. et al. Acceptability, accuracy, and safety of disposable transnasal capsule endoscopy for Barrett\u2019s esophagus screening. Clin. Gastroenterol. Hepatol. 17, 638\u2013646 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR160","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cgh.2013.10.014","volume":"12","author":"B Alashkar","year":"2014","unstructured":"Alashkar, B. et al. Development of a program to train physician extenders to perform transnasal esophagoscopy and screen for Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 12, 785\u2013792 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR161","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1572-0241.2007.01233.x","volume":"103","author":"P Sharma","year":"2008","unstructured":"Sharma, P. et al. The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett\u2019s esophagus: a blinded, prospective study. Am. J. Gastroenterol. 103, 525\u2013532 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR162","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/ajg.2009.86","volume":"104","author":"A Bhardwaj","year":"2009","unstructured":"Bhardwaj, A., Hollenbeak, C. S., Pooran, N. & Mathew, A. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett\u2019s esophagus in patients with gastroesophageal reflux disease. Am. J. Gastroenterol. 104, 1533\u20131539 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4664-3","volume":"18","author":"J Offman","year":"2018","unstructured":"Offman, J. et al. Barrett\u2019s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 18, 784 (2018).","journal-title":"BMC Cancer"},{"key":"86_CR164","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41395-018-0107-7","volume":"113","author":"PG Iyer","year":"2018","unstructured":"Iyer, P. G. et al. Highly discriminant methylated DNA markers for the non-endoscopic detection of Barrett\u2019s esophagus. Am. J. Gastroenterol. 113, 1156\u20131166 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR165","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5848","volume":"10","author":"HR Moinova","year":"2018","unstructured":"Moinova, H. R. et al. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett\u2019s esophagus. Sci. Transl Med. 10, eaao5848 (2018).","journal-title":"Sci. Transl Med."},{"key":"86_CR166","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1136\/gutjnl-2017-314026","volume":"67","author":"H Chettouh","year":"2018","unstructured":"Chettouh, H. et al. Methylation panel is a diagnostic biomarker for Barrett\u2019s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut 67, 1942\u20131949 (2018).","journal-title":"Gut"},{"key":"86_CR167","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.gastro.2018.05.050","volume":"155","author":"X Li","year":"2018","unstructured":"Li, X. et al. Selection and application of tissue microRNAs for nonendoscopic diagnosis of Barrett\u2019s esophagus. Gastroenterology 155, 771\u2013783 (2018).","journal-title":"Gastroenterology"},{"key":"86_CR168","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2016.11.001","volume":"152","author":"DK Chan","year":"2017","unstructured":"Chan, D. K. et al. Breath testing for Barrett\u2019s esophagus using exhaled volatile organic compound profiling with an electronic nose device. Gastroenterology 152, 24\u201326 (2017).","journal-title":"Gastroenterology"},{"key":"86_CR169","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.gie.2018.10.024","volume":"89","author":"J Honing","year":"2018","unstructured":"Honing, J. et al. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett\u2019s esophagus in patients with GERD symptoms. Gastrointest. Endosc. 89, 712\u2013722 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR170","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1067\/mge.2003.101","volume":"57","author":"PJ Nietert","year":"2003","unstructured":"Nietert, P. J. et al. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest. Endosc. 57, 311\u2013318 (2003).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR171","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","volume":"138","author":"JM Inadomi","year":"2003","unstructured":"Inadomi, J. M. et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann. Intern. Med. 138, 176\u2013186 (2003).","journal-title":"Ann. Intern. Med."},{"key":"86_CR172","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1542-3565(04)00394-5","volume":"2","author":"LB Gerson","year":"2004","unstructured":"Gerson, L. B., Groeneveld, P. W. & Triadafilopoulos, G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 2, 868\u2013879 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR173","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.cgh.2017.02.017","volume":"15","author":"CR Heberle","year":"2017","unstructured":"Heberle, C. R. et al. Cost effectiveness of screening patients with gastroesophageal reflux disease for Barrett\u2019s esophagus with a minimally invasive cell sampling device. Clin. Gastroenterol. Hepatol. 15, 1397\u20131404 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR174","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.gie.2017.10.011","volume":"87","author":"S Wani","year":"2018","unstructured":"Wani, S. et al. Endoscopic eradication therapy for patients with Barrett\u2019s esophagus-associated dysplasia and intramucosal cancer. Gastrointest. Endosc. 87, 907\u2013931 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR175","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1053\/j.gastro.2013.05.004","volume":"145","author":"DA Corley","year":"2013","unstructured":"Corley, D. A. et al. Impact of endoscopic surveillance on mortality from Barrett\u2019s esophagus-associated esophageal adenocarcinomas. Gastroenterology 145, 312\u2013319 (2013).","journal-title":"Gastroenterology"},{"key":"86_CR176","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6590-5","author":"D Holmberg","year":"2018","unstructured":"Holmberg, D., Ness-Jensen, E., Mattsson, F. & Lagergren, J. Clinical prediction model for tumor progression in Barrett\u2019s esophagus. Surg. Endosc. https:\/\/doi.org\/10.1007\/s00464-018-6590-5 (2018).","journal-title":"Surg. Endosc."},{"key":"86_CR177","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.gie.2007.08.039","volume":"67","author":"FP Peters","year":"2008","unstructured":"Peters, F. P. et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett\u2019s esophagus. Gastrointest. Endosc. 67, 604\u2013609 (2008).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR178","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/gutjnl-2015-311237","volume":"67","author":"SR Markar","year":"2018","unstructured":"Markar, S. R. et al. The influence of procedural volume and proficiency gain on mortality from upper GI endoscopic mucosal resection. Gut 67, 79\u201385 (2018).","journal-title":"Gut"},{"key":"86_CR179","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.gastro.2013.11.006","volume":"146","author":"O Pech","year":"2014","unstructured":"Pech, O. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146, 652\u2013660 (2014).","journal-title":"Gastroenterology"},{"key":"86_CR180","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.gie.2017.01.027","volume":"86","author":"S Subramaniam","year":"2017","unstructured":"Subramaniam, S. et al. Complex early Barrett\u2019s neoplasia at 3 Western centers: European Barrett\u2019s Endoscopic Submucosal Dissection Trial (E-BEST). Gastrointest. Endosc. 86, 608\u2013618 (2017).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR181","first-page":"829","volume":"47","author":"P Pimentel-Nunes","year":"2015","unstructured":"Pimentel-Nunes, P. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47, 829\u2013854 (2015).","journal-title":"Endoscopy (ESGE) Guideline. Endoscopy"},{"key":"86_CR182","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/gutjnl-2015-310126","volume":"66","author":"G Terheggen","year":"2017","unstructured":"Terheggen, G. et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett\u2019s neoplasia. Gut 66, 783\u2013793 (2017).","journal-title":"Gut"},{"key":"86_CR183","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.gie.2017.09.038","volume":"87","author":"D Yang","year":"2018","unstructured":"Yang, D. et al. Endoscopic submucosal dissection for early Barrett\u2019s neoplasia: a meta-analysis. Gastrointest. Endosc. 87, 1383\u20131393 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR184","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/ajg.2013.187","volume":"108","author":"Y Tomizawa","year":"2013","unstructured":"Tomizawa, Y. et al. Safety of endoscopic mucosal resection for Barrett\u2019s esophagus. Am. J. Gastroenterol. 108, 1440\u20131447 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR185","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","volume":"141","author":"NJ Shaheen","year":"2011","unstructured":"Shaheen, N. J. et al. Durability of radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. Gastroenterology 141, 460\u2013468 (2011).","journal-title":"Gastroenterology"},{"key":"86_CR186","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jama.2014.2511","volume":"311","author":"KN Phoa","year":"2014","unstructured":"Phoa, K. N. et al. Radiofrequency ablation versus endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 311, 1209\u20131217 (2014).","journal-title":"JAMA"},{"key":"86_CR187","first-page":"6","volume":"46","author":"H Manner","year":"2014","unstructured":"Manner, H. et al. Ablation of residual Barrett\u2019s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation versus surveillance (APE study). Endoscopy 46, 6\u201312 (2014).","journal-title":"Endoscopy"},{"key":"86_CR188","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10620-018-5009-4","volume":"63","author":"PN Thota","year":"2018","unstructured":"Thota, P. N. et al. Cryotherapy and radiofrequency ablation for eradication of Barrett\u2019s esophagus with dysplasia or intramucosal cancer. Dig. Dis. Sci. 63, 1311\u20131319 (2018).","journal-title":"Dig. Dis. Sci."},{"key":"86_CR189","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.gie.2009.02.006","volume":"70","author":"JA Dumot","year":"2009","unstructured":"Dumot, J. A. et al. An open-label, prospective trial of cryospray ablation for Barrett\u2019s esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest. Endosc. 70, 635\u2013644 (2009).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR190","first-page":"367","volume":"2","author":"M Milashka","year":"2014","unstructured":"Milashka, M. et al. Sixteen-year follow-up of Barrett\u2019s esophagus, endoscopically treated with argon plasma coagulation. United European Gastroenterol. J. 2, 367\u2013373 (2014).","journal-title":"Gastroenterol. J."},{"key":"86_CR191","first-page":"383","volume":"2","author":"H Manner","year":"2014","unstructured":"Manner, H. et al. The tissue effect of argon-plasma coagulation with prior submucosal injection (Hybrid-APC) versus standard APC: a randomized ex-vivo study. United European Gastroenterol. J. 2, 383\u2013390 (2014).","journal-title":"Gastroenterol. J."},{"key":"86_CR192","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cgh.2013.03.039","volume":"11","author":"ES Orman","year":"2013","unstructured":"Orman, E. S., Li, N. & Shaheen, N. J. Efficacy and durability of radiofrequency ablation for Barrett\u2019s Esophagus: systematic review and meta-analysis. Clin.\u00a0Gastroenterol. Hepatol. 11, 1245\u20131255 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR193","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cgh.2013.07.013","volume":"12","author":"M Anders","year":"2014","unstructured":"Anders, M. et al. Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 12, 405\u2013410 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR194","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/ajg.2011.255","volume":"106","author":"NA Gray","year":"2011","unstructured":"Gray, N. A., Odze, R. D. & Spechler, S. J. Buried metaplasia after endoscopic ablation of Barrett\u2019s esophagus: a systematic review. Am. J. Gastroenterol. 106, 1899\u20131908 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR195","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gie.2017.04.018","volume":"87","author":"K Belghazi","year":"2018","unstructured":"Belghazi, K. et al. Long-term follow-up results of stepwise radical endoscopic resection for Barrett\u2019s esophagus with early neoplasia. Gastrointest. Endosc. 87, 77\u201384 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR196","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.gie.2016.09.022","volume":"85","author":"M Desai","year":"2017","unstructured":"Desai, M. et al. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett\u2019s esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest. Endosc. 85, 482\u2013495 (2017).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR197","doi-asserted-by":"publisher","first-page":"523","DOI":"10.5946\/ce.2014.47.6.523","volume":"47","author":"JW Cho","year":"2014","unstructured":"Cho, J. W. et al. Lymph node metastases in esophageal carcinoma: an endoscopist\u2019s view. Clin. Endosc. 47, 523\u2013529 (2014).","journal-title":"Clin. Endosc."},{"key":"86_CR198","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1111\/j.1572-0241.2008.02083.x","volume":"103","author":"H Manner","year":"2008","unstructured":"Manner, H. et al. Early Barrett\u2019s carcinoma with \u201clow-risk\u201d submucosal invasion: long-term results of endoscopic resection with a curative intent. Am. J. Gastroenterol. 103, 2589\u20132597 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR199","doi-asserted-by":"crossref","unstructured":"Manner, H. et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin. Gastroenterol. Hepatol. 11, 630\u2013635 (2013).","DOI":"10.1016\/j.cgh.2012.12.040"},{"key":"86_CR200","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.gastro.2018.04.011","volume":"155","author":"CC Cotton","year":"2018","unstructured":"Cotton, C. C., Haidry, R., Thrift, A. P., Lovat, L. & Shaheen, N. J. Development of evidence-based surveillance intervals after radiofrequency ablation of Barrett\u2019s esophagus. Gastroenterology 155, 316\u2013326 (2018). This article provides evidence-based surveillance intervals for patients with endoscopically treated BE.","journal-title":"Gastroenterology"},{"key":"86_CR201","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S2468-1253(17)30213-3","volume":"3","author":"J Britton","year":"2018","unstructured":"Britton, J. et al. Effect of diagnosis, surveillance, and treatment of Barrett\u2019s oesophagus on health-related quality of life. Lancet Gastroenterol. Hepatol. 3, 57\u201365 (2018). This paper presents a comprehensive review of the QOL in patients with BE.","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"86_CR202","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00464-002-9229-4","volume":"17","author":"T Kamolz","year":"2003","unstructured":"Kamolz, T., Pointner, R. & Velanovich, V. The impact of gastroesophageal reflux disease on quality of life. Surg. Endosc. 17, 1193\u20131199 (2003).","journal-title":"Surg. Endosc."},{"key":"86_CR203","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0002-9270(03)00010-8","volume":"98","author":"JJ Ofman","year":"2003","unstructured":"Ofman, J. J. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am. J. Gastroenterol. 98, S8\u2013S14 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR204","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/j.1572-0241.2000.02235.x","volume":"95","author":"MA Eloubeidi","year":"2000","unstructured":"Eloubeidi, M. A. & Provenzale, D. Health-related quality of life and severity of symptoms in patients with Barrett\u2019s esophagus and gastroesophageal reflux disease patients without Barrett\u2019s esophagus. Am. J. Gastroenterol. 95, 1881\u20131887 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR205","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","volume":"18","author":"M Kulig","year":"2003","unstructured":"Kulig, M. et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease \u2014 an analysis based on the ProGERD initiative. Aliment. Pharmacol. Ther. 18, 767\u2013776 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"86_CR206","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1038\/ajg.2009.504","volume":"104","author":"QK Lippmann","year":"2009","unstructured":"Lippmann, Q. K., Crockett, S. D., Dellon, E. S. & Shaheen, N. J. Quality of life in GERD and Barrett\u2019s esophagus is related to gender and manifestation of disease. Am. J. Gastroenterol. 104, 2695\u20132703 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR207","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.510300504","volume":"30","author":"AJ Rodger","year":"1999","unstructured":"Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A. & Crofts, N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30, 1299\u20131301 (1999).","journal-title":"Hepatology"},{"key":"86_CR208","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.mcg.0000196186.19426.4a","volume":"40","author":"JH Rubenstein","year":"2006","unstructured":"Rubenstein, J. H. & Inadomi, J. M. Defining a clinically significant adverse impact of diagnosing Barrett\u2019s esophagus. J. Clin. Gastroenterol. 40, 109\u2013115 (2006).","journal-title":"J. Clin. Gastroenterol."},{"key":"86_CR209","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11136-007-9239-8","volume":"16","author":"ML Essink-Bot","year":"2007","unstructured":"Essink-Bot, M. L. et al. Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groups. Qual. Life Res. 16, 1309\u20131318 (2007).","journal-title":"Qual. Life Res."},{"key":"86_CR210","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/MEG.0b013e328318ed2d","volume":"21","author":"SC Cooper","year":"2009","unstructured":"Cooper, S. C. et al. Endoscopic surveillance for Barrett\u2019s oesophagus: the patients\u2019 perspective. Eur. J. Gastroenterol. Hepatol. 21, 850\u2013854 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"86_CR211","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1572-0241.2000.02002.x","volume":"95","author":"DS Levine","year":"2000","unstructured":"Levine, D. S., Blount, P. L., Rudolph, R. E. & Reid, B. J. Safety of a systematic endoscopic biopsy protocol in patients with Barrett\u2019s esophagus. Am. J. Gastroenterol. 95, 1152\u20131157 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR212","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1055\/s-2006-944613","volume":"38","author":"ME Kruijshaar","year":"2006","unstructured":"Kruijshaar, M. E. et al. The burden of upper gastrointestinal endoscopy in patients with Barrett\u2019s esophagus. Endoscopy 38, 873\u2013878 (2006).","journal-title":"Endoscopy"},{"key":"86_CR213","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gie.2006.05.018","volume":"65","author":"LB Gerson","year":"2007","unstructured":"Gerson, L. B., Ullah, N., Hastie, T. & Goldstein, M. K. Does cancer risk affect health-related quality of life in patients with Barrett\u2019s esophagus? Gastrointest. Endosc. 65, 16\u201325 (2007).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR214","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0091-7435(84)90044-6","volume":"13","author":"FA Macrae","year":"1984","unstructured":"Macrae, F. A., Hill, D. J., St John, D. J., Ambikapathy, A. & Garner, J. F. Predicting colon cancer screening behavior from health beliefs. Prev. Med. 13, 115\u2013126 (1984).","journal-title":"Prev. Med."},{"key":"86_CR215","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gie.2006.05.030","volume":"65","author":"ME Kruijshaar","year":"2007","unstructured":"Kruijshaar, M. E. et al. Patients with Barrett\u2019s esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest. Endosc. 65, 26\u201330 (2007).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR216","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1177\/2050640618798508","volume":"6","author":"MCM van der Ende-van Loon","year":"2018","unstructured":"van der Ende-van Loon, M. C. M., Rosmolen, W. D., Houterman, S., Schoon, E. J. & Curvers, W. L. Cancer risk perception in relation to associated symptoms in Barrett\u2019s patients: a cross sectional study on quality of life. United European Gastroenterol. J. 6, 1316\u20131322 (2018).","journal-title":"United European Gastroenterol. J."},{"key":"86_CR217","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.gastro.2005.05.055","volume":"129","author":"NJ Shaheen","year":"2005","unstructured":"Shaheen, N. J. et al. The perception of cancer risk in patients with prevalent Barrett\u2019s esophagus enrolled in an endoscopic surveillance program. Gastroenterology 129, 429\u2013436 (2005).","journal-title":"Gastroenterology"},{"key":"86_CR218","doi-asserted-by":"publisher","first-page":"dox109","DOI":"10.1093\/dote\/dox109","volume":"31","author":"MW Stier","year":"2018","unstructured":"Stier, M. W. et al. Perceptions of risk and therapy among patients with Barrett\u2019s esophagus: a patient survey study. Dis. Esophagus 31, dox109 (2018).","journal-title":"Dis. Esophagus"},{"key":"86_CR219","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth, E. C. et al. Oesophageal cancer. Nat. Rev. Dis. Primers 3, 17048 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"86_CR220","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1055\/s-0030-1255780","volume":"42","author":"NJ Shaheen","year":"2010","unstructured":"Shaheen, N. J. et al. Quality of life following radiofrequency ablation of dysplastic Barrett\u2019s esophagus. Endoscopy 42, 790\u2013799 (2010).","journal-title":"Endoscopy"},{"key":"86_CR221","first-page":"1","volume":"30","author":"WD Rosmolen","year":"2017","unstructured":"Rosmolen, W. D. et al. Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett\u2019s neoplasia: a prospective study. Dis. Esophagus 30, 1\u20139 (2017).","journal-title":"Dis. Esophagus"},{"key":"86_CR222","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1055\/s-0029-1244222","volume":"42","author":"WD Rosmolen","year":"2010","unstructured":"Rosmolen, W. D. et al. Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett\u2019s esophagus. Endoscopy 42, 525\u2013531 (2010).","journal-title":"Endoscopy"},{"key":"86_CR223","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gutjnl-2014-308501","volume":"64","author":"RJ Haidry","year":"2015","unstructured":"Haidry, R. J. et al. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett\u2019s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 64, 1192\u20131199 (2015).","journal-title":"Gut"},{"key":"86_CR224","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ajg.2017.18","volume":"112","author":"T Nguyen","year":"2017","unstructured":"Nguyen, T., Thrift, A. P., Yu, X., Duan, Z. & El-Serag, H. B. The annual risk of esophageal adenocarcinoma does not decrease over time in patients with Barrett\u2019s esophagus. Am. J. Gastroenterol. 112, 1049\u20131055 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"86_CR225","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0969141315575052","volume":"22","author":"O Old","year":"2015","unstructured":"Old, O. et al. Barrett\u2019s Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial. J. Med. Screen. 22, 158\u2013164 (2015). This article presents a study protocol for a randomized study that will provide data to evaluate the efficacy and cost-effectiveness of screening patients with BE for the presence of EAC.","journal-title":"J. Med. Screen."},{"key":"86_CR226","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.gie.2018.02.021","volume":"87","author":"K Visrodia","year":"2018","unstructured":"Visrodia, K. et al. Cryotherapy for persistent Barrett\u2019s esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest. Endosc. 87, 1396\u20131404 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR227","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/gut.2010.221648","volume":"60","author":"H Kazumori","year":"2011","unstructured":"Kazumori, H., Ishihara, S., Takahashi, Y., Amano, Y. & Kinoshita, Y. Roles of Kruppel-like factor 4 in oesophageal epithelial cells in Barrett\u2019s epithelium development. Gut 60, 608\u2013617 (2011).","journal-title":"Gut"},{"key":"86_CR228","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1172\/JCI66603","volume":"124","author":"DH Wang","year":"2014","unstructured":"Wang, D. H. et al. Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett\u2019s metaplasia. J. Clin. Invest. 124, 3767\u20133780 (2014).","journal-title":"J. Clin. Invest."},{"key":"86_CR229","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/jgh.12230","volume":"28","author":"J Andrici","year":"2013","unstructured":"Andrici, J., Cox, M. R. & Eslick, G. D. Cigarette smoking and the risk of Barrett\u2019s esophagus: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 28, 1258\u20131273 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"86_CR230","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2008.12.005","volume":"136","author":"LA Anderson","year":"2009","unstructured":"Anderson, L. A. et al. The association between alcohol and reflux esophagitis, Barrett\u2019s esophagus, and esophageal adenocarcinoma. Gastroenterology 136, 799\u2013805 (2009).","journal-title":"Gastroenterology"},{"key":"86_CR231","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","volume":"5","author":"T Rokkas","year":"2007","unstructured":"Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I. & Margantinis, G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin. Gastroenterol. Hepatol. 5, 1413\u20131417 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"86_CR232","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/PAS.0000000000000988","volume":"42","author":"MA Salomao","year":"2018","unstructured":"Salomao, M. A., Lam-Himlin, D. & Pai, R. K. Substantial interobserver agreement in the diagnosis of dysplasia in Barrett esophagus upon review of a patient\u2019s entire set of biopsies. Am. J. Surg. Pathol. 42, 376\u2013381 (2018).","journal-title":"Am. J. Surg. Pathol."},{"key":"86_CR233","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/hupa.2001.23510","volume":"32","author":"E Montgomery","year":"2001","unstructured":"Montgomery, E. et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum. Pathol. 32, 368\u2013378 (2001).","journal-title":"Hum. Pathol."},{"key":"86_CR234","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai, T. K. et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut 61, 970\u2013976 (2012).","journal-title":"Gut"},{"key":"86_CR235","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1365-2559.2010.03571.x","volume":"56","author":"SA Sonwalkar","year":"2010","unstructured":"Sonwalkar, S. A. et al. A study of indefinite for dysplasia in Barrett\u2019s oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase). Histopathology 56, 900\u2013907 (2010).","journal-title":"Histopathology"},{"key":"86_CR236","first-page":"409","volume":"47","author":"C Kestens","year":"2015","unstructured":"Kestens, C., Leenders, M., Offerhaus, G. J., van Baal, J. W. & Siersema, P. D. Risk of neoplastic progression in Barrett\u2019s esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study. Endoscopy 47, 409\u2013414 (2015).","journal-title":"Endoscopy"},{"key":"86_CR237","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.gie.2014.01.009","volume":"79","author":"S Singh","year":"2014","unstructured":"Singh, S. et al. Incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest. Endosc. 79, 897\u2013909 (2014).","journal-title":"Gastrointest. Endosc."},{"key":"86_CR238","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/jcp.2010.080721","volume":"63","author":"BA Grotenhuis","year":"2010","unstructured":"Grotenhuis, B. A. et al. Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma. J. Clin. Pathol. 63, 978\u2013981 (2010).","journal-title":"J. Clin. Pathol."},{"key":"86_CR239","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","volume":"50","author":"M Kerkhof","year":"2007","unstructured":"Kerkhof, M. et al. Grading of dysplasia in Barrett\u2019s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50, 920\u2013927 (2007).","journal-title":"Histopathology"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0086-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T12:34:00Z","timestamp":1721306040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0086-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":239,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1038\/s41572-019-0086-z","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"23 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.J.S. has received research grants from Medtronic, CSA Medical, C2 Therapeutics, CDx Medical, EndoStim and Interpace Diagnostics and has served as a consultant for Pfizer, Boston Scientific and Shire. A.C. has equity interest in and is a consultant for Lucid Diagnostics. R.F.S. has served as a consultant and receives research support from Ironwood Pharmaceuticals. M.D.P. has received educational grants from Olympus and Medtronic and has served as consultant for Medtronic. P.G.I. has received research funding from Exact Sciences, Pentax Medical, Symple Surgical, Nine Point Medical and Medtronic and has served as a consultant for Medtronic, Symple Surgical and CSA Medical. O.P. has a speaker honorarium from Olympus, Fujifilm, Medtronic, Boston Scientific and Cook. R.C.F. is named on patents related to the Cytosponge and associated assays, which have been licensed to Covidien (now Medtronic), and has served as a consultant to Medtronic. P.D.S. has received research funding from Pentax Medical, EndoStim, Yakult, OncoDNA and Ella-CS. Y.P., A.A.-K. and A.B. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}